Načítá se...
Role of novel biomarkers in diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM) is commonly defined as cardiomyopathy in patients with diabetes mellitus in the absence of coronary artery disease and hypertension. As DCM is now recognized as a cause of substantial morbidity and mortality among patients with diabetes mellitus and clinical diagnosis i...
Uloženo v:
| Vydáno v: | World J Diabetes |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8192249/ https://ncbi.nlm.nih.gov/pubmed/34168722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v12.i6.685 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|